Vasoactive Intestinal Peptide Induces an Immunosuppressant Microenvironment in the Maternal–Fetal Interface of Non-Obese Diabetic Mice and Improves Early Pregnancy Outcome
Article first published online: 28 OCT 2013
© 2013 John Wiley & Sons Ltd
American Journal of Reproductive Immunology
Volume 71, Issue 2, pages 120–130, February 2014
How to Cite
VIP induces an immunosuppressant microenvironment in the maternal–fetal interface of non-obese diabetic mice and improves early pregnancy outcome. Am J Reprod Immunol 2014; 71: 120–130, , , , , , , .
- Issue published online: 10 JAN 2014
- Article first published online: 28 OCT 2013
- Manuscript Accepted: 18 SEP 2013
- Manuscript Received: 3 JUL 2013
- National Agency of Sciences and Technology ANPCyT. Grant Number: PICT 2011-0144
- National Research Council CONICET. Grant Number: PIP 2012-2015
- University of Buenos Aires. Grant Numbers: UBACyT 20020100100505, UBACyT 20020090200034
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.